Phathom Pharmaceuticals Q2 EPS $(1.00) Down From $(0.64) YoY

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.00) per share. This is a 56.25 percent decrease over losses of $(0.64) per share from the same period last year.

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.00) per share. This is a 56.25 percent decrease over losses of $(0.64) per share from the same period last year.

Total
0
Shares
Related Posts